Case Study: Skin Infection in a Diabetic Patient Related to Contamination of an Insulin Bottle
- Irma Gazeroglu, MD,
- Michael Borenstein, MD, PhD and
- Maria P. Solano, MD
Presentation
D.P. is a 59-year-old white Hispanic woman with a 12-year history of type 2 diabetes treated with a thiazolidindione and multiple daily injections of insulin. She presented to the outpatient clinic with a 10-week history of painful skin lesions on her abdomen that had been increasing in size. The lesions developed at the site of insulin injections. She was injecting in the abdomen, using a new needle each time. She had received a 14-day course of levofloxacin 7 weeks before the clinic visit and had been instructed to change the insulin bottles and to use her arms for injection. The skin lesions did not seem to improve, but she did not developed new lesions. She denied fever or other constitutional symptoms.
Her medical history was significant for severe asthma requiring chronic oral steroids and hypertension. …
